联系电话:0510-83594580

NEWS

Lenmeldy——The most expensive drug in the word at present

Time: 2024-03-26

Wuxi Further Pharmaceutical Co.,Ltd.

 Add: Huishan Life Science and Technology Industrial Park, Huishan District, Wuxi, China

Whatsapp: + 86 18036885286;  Email: wuxifurther@gmail.com 

 

Lenmeldy——The most expensive drug in the word at present

        Worldwide, the therapeutics market is already flooded with therapies that cost more than $1 million per dose. At least 10 drugs (As following table ) have reached this milestone, mainly gene therapies, but also small molecule drug modalities. Recently, the one-time gene therapy Lenmeldy for early-onset metachromatic leukodystrophy (MLD) of Orchard Therapeutics has been approved by the FDA for sale, priced at $4.25 million, raising the price of the world's most expensive drug by 21%.

 

Drug name

Price/Dose(Million $)

Indications

Manufacturers

Approval time

Therapy Methods

Lenmeldy

4.25

Metachromatic Leukodystrophy(MLD)

Orchard Therapeutics

2024.3.18

Gene therapy

Hemgenix

3.50

Hemophilia B

CSL Behring and uniQure

2022.11.22

Gene therapy

Skysona

3.00

CALD

Bluebird Bio

2022.9.18

Gene therapy

Zynteglo

2.80

βThalassemia

Bluebird Bio

2022.8.17

Gene therapy

Zolgensma

2.10

SMA

Nuohua

2019.5.26

Gene therapy

Lamzede

1.46

Alpha-mannoside storage syndrome

Chiesi

2023.2.16

Enzyme replacement therapy

Myalept

1.26

Systemic lipodystrophy

Chiesi Farmaceutici

2014.2.25

Protein

Sohonos

1.40

FOP

Ipsen

2023.8.16

Micromolecule

 

Zokinvy

 

1.00

Hutchinson-Gilford

EigerBioPharmaceuticals

2020.11.20

Micromolecule

Danyelza

1.00

 Refractory neuroblastoma in bone or bone marrow

Y-mAbs Therapeutics

2020.11.25

McAb(monoclonal antibody)

 

About us  |   R&D And Services  |   Products  |   Manufacturing Center  |   News  |   Downloads  |   Contact us  |   中文版

Copyright(C)2022, Wuxi Further Pharmaceutical Co., Ltd. All Rights Reserved. Supported by ChinaChemNet ChemNet Toocle Copyright Notice 备案序号:苏ICP备14012706号

展开